Inactive Instrument

News Nymox Pharmaceutical Corporation Nasdaq

Equities

CA67076P1027

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages	03-27	GL
OTC F-Stocks Holiday Momentum Watchlist (TBRIF, PYRGF, NYMXF, MGDPF)	12-28	AQ
Nymox December 27 Message to Shareholders	12-27	GL
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others	11-30	GL
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court	11-21	GL
Nymox: Q3 Earnings Snapshot	11-15	AQ
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15	CI
Nymox Pharmaceutical : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K	11-15	PU
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million	11-09	GL
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized	11-03	GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	11-03	GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	11-03	AQ
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations	11-02	GL
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting	23-10-31	GL
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting	23-10-27	GL
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review	23-10-26	GL
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	23-09-25	GL
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	23-09-25	CI
Nymox Reports Completion of $2 Million Private Placement	23-08-29	GL
Nymox Pharmaceutical Corporation announced that it has received $2 million in funding	23-08-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nymox Pharmaceutical Corporation Nasdaq

Equities

CA67076P1027

Summary

Filters